FDA Seeks Input On Ways To Update Clinical Pharmacology Policies

FDA is soliciting comments on what policy topics should be developed, prioritized or implemented by the drug center’s Office of Clinical Pharmacology (OCP) to promote effective research on drug development. The request for comment is scheduled to be published in the Federal Register Friday (April 26). FDA says in the notice it is looking for “specific, actionable policy suggestions” from stakeholders in the field of clinical pharmacology that OCP staff can implement in the near term. Areas of particular...